PharmaEngine (4162) — Free Cash Flow Generation Index
PharmaEngine (4162) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of NT$52.90 Million represents 1% of operating cash flow (NT$53.01 Million). See PharmaEngine (4162) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
PharmaEngine Free Cash Flow Generation Index (2011–2024)
Historical FCF Generation Index trend for PharmaEngine across 12 annual periods. Explore PharmaEngine debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for PharmaEngine (2011–2024)
Year-by-year Free Cash Flow Generation Index for PharmaEngine. For the full company profile including market capitalisation, see 4162 company net worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.00x | NT$455.32 Million | NT$456.73 Million | NT$1.42 Million | ▲ +0.1% |
| 2023 | 1.00x | NT$256.01 Million | NT$256.97 Million | NT$958.00K | ▲ +1.6% |
| 2022 | 0.98x | NT$198.07 Million | NT$202.01 Million | NT$3.94 Million | ▼ -1.9% |
| 2021 | 1.00x | NT$929.44 Million | NT$929.67 Million | NT$229.00K | ▲ +0.9% |
| 2020 | 0.99x | NT$64.16 Million | NT$64.77 Million | NT$608.00K | ▲ +0.4% |
| 2019 | 0.99x | NT$15.87 Million | NT$16.08 Million | NT$208.00K | ▼ -1.2% |
| 2018 | 1.00x | NT$744.72 Million | NT$745.23 Million | NT$510.00K | ▲ +0.1% |
| 2016 | 1.00x | NT$869.24 Million | NT$870.38 Million | NT$1.15 Million | ▲ +2.6% |
| 2015 | 0.97x | NT$436.19 Million | NT$447.99 Million | NT$11.80 Million | ▼ -2.6% |
| 2014 | 1.00x | NT$130.99 Million | NT$131.09 Million | NT$95.00K | ▲ +0.0% |
| 2012 | 1.00x | NT$68.56 Million | NT$68.64 Million | NT$83.00K | ▲ +0.2% |
| 2011 | 1.00x | NT$274.68 Million | NT$275.49 Million | NT$806.00K | — |